Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 179.00
-1.00 (-0.56%)
Aug 27, 2026, 12:42 PM JST
Kidswell Bio Market Cap
Kidswell Bio has a market cap or net worth of 9.1 billion as of August 26, 2026. Its market cap has decreased by -20.04% in one year.
Market Cap
9.10B
Enterprise Value
8.35B
Revenue
6.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
179.00
ChartMarket Cap Chart
Since November 30, 2012, Kidswell Bio's market cap has increased from 2.73B to 9.10B, an increase of 233.09%. That is a compound annual growth rate of 9.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 9.10B | -9.58% |
| Dec 30, 2025 | 10.07B | 125.16% |
| Dec 30, 2024 | 4.47B | -11.75% |
| Dec 29, 2023 | 5.07B | -40.50% |
| Dec 30, 2022 | 8.52B | -45.05% |
| Dec 30, 2021 | 15.50B | 7.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 10.54B |
| Immuno-Biological Laboratories | 9.91B |
| SUSMED,Inc. | 9.57B |
| Nano Holdings | 9.21B |
| CellSeed | 9.19B |
| K Pharma,Inc. | 8.96B |
| Carna Biosciences | 8.86B |
| OncoTherapy Science | 8.57B |